Advertisement

Topics

EpiPen maker to settle on claims it overcharged taxpayers, agrees to have pricing practices reviewed

16:24 EDT 17 Aug 2017 | STAT

The $465 million payment is fraction of the estimated $1.27 billion Mylan was said to have overcharged Medicaid.

Original Article: EpiPen maker to settle on claims it overcharged taxpayers, agrees to have pricing practices reviewed

NEXT ARTICLE

More From BioPortfolio on "EpiPen maker to settle on claims it overcharged taxpayers, agrees to have pricing practices reviewed"

Advertisement
Quick Search
Advertisement
Advertisement